The paracaspase MALT1 cleaves and removes negative checkpoint proteins, amplifying lymphocyte responses in NF-κB activation and in B-cell lymphoma subtypes. This evidence concerns the gene NFKB1 and B-cell non-Hodgkin lymphoma.